Serum Levels of Endostatin, an Angiogenesis Inhibitor, in Patients With Benign and Malignant Lesions of the Breast (original) (raw)
Related papers
Estrogen Plus Progestin Therapy and Breast Cancer in Recently Postmenopausal Women
American Journal of Epidemiology, 2008
Endometriosis-associated Malignancy
Geburtshilfe Und Frauenheilkunde, 2016
Histopathology, 2000
Breast Diseases: A Year Book Quarterly, 2013
Tamoxifen and fenretinide in women with metastatic breast cancer
Breast Cancer Research and Treatment, 1999
Angiogenesis and Vasculogenesis in Health and Disease
BioMed Research International, 2015
Prognostic Significance of Complete Blood Count in Breast Cancer Patients
2016
Stimulation of Human Breast Cancer in Vivo
Annals of the New York Academy of Sciences, 1993
Aromatase inhibitors in breast cancer
Manisha Kotadiya, jaydeep savaliya
The American Journal of Geriatric Pharmacotherapy, 2004
High serum follistatin levels in women with ovarian endometriosis
Fertility and Sterility, 2007
Risk Factors Leading to High Prevalence of Breast Cancer
Journal of Applied Pharmacy, 2013
Didier Wion, Christine Ménétrier-caux
British journal of cancer, 2006
Environmental Health Perspectives, 2007
Journal of the American Geriatrics Society, 2001
Cardiovascular Dysautonomia in Patients with Breast Cancer
The Open Cardiovascular Medicine Journal, 2022
Journal of Surgical Oncology, 2000
Second consensus on medical treatment of metastatic breast cancer
Annals of Oncology, 2006
Association of breast cancer with meningioma
European Journal of Surgical Oncology (EJSO), 1998
The Next Steps for Endocrine Pathology
Endocrine Pathology, 2022
Systemic Therapy of Metastatic Breast Cancer
Acta Oncologica, 1990
2023
Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer
Oncogene, 2003
Angiopoietins in Human Breast Milk
Breastfeeding Medicine, 2016
Cyclin D1, Id1 and EMT in breast cancer
BMC cancer, 2011
Blood-Based Biomarkers of Early-Onset Breast Cancer
2014